Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Les Entreprises Solumed

1990 FOUNDED
M&A STATUS
21-30 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of skin asepsis (infection prevention) products designed to provide intravenous therapy, preoperative care, operating room care, home care and hand hygiene. The company's skin asepsis (infection prevention) products specializes in unit-dose and multidose packaging of pharmaceuticals containing active ingredients enabling patients to prevent infections in operating rooms and hospitals.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
3M Canada
Primary Office
  • 2109, rue Le Chatelier
  • Laval, Quebec H7L 5B3
  • Canada

Les Entreprises Solumed Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Les Entreprises Solumed‘s full profile, request access.

Request full access to PitchBook

Les Entreprises Solumed Executive Team (1)

Name Title Board
Seat
Contact
Info
Marc Petry President